Castle Biosciences Study Supports Molecular Guidance in AD
Friendswood, Texas, U.S., September 24, 2026 Castle Biosciences, Inc. has announced findings from a new study highlighting the potential...
biologics
Advertisement
Henlius Partners With Amberstone on Next-Gen TCEs
Shanghai, China, September 24, 2026 Henlius has announced a strategic partnership with Amberstone Biosciences to discover and develop next-generation...
Flen Health and AGC Biologics Advance Enzyme Wound Therapy
Heidelberg, Germany, September 24, 2026 Flen Health has selected AGC Biologics as its contract development and manufacturing organization (CDMO)...
Aptar Pharma and Macquarie University Advance Inhaled Biologics Research
SYDNEY, Australia — September 25, 2026 Aptar Pharma announced a new three-year research collaboration with Macquarie University supported by...
Oruka Reports Positive Week 28 ORKA-001 Psoriasis Data
MENLO PARK, Calif. — September 23, 2026 Oruka Therapeutics announced positive Week 28 data from the ongoing EVERLAST-A Phase...
Advertisements
Applied Biologics Completes CAMPX Patient Follow-Up
SCOTTSDALE, Ariz. — September 22, 2026 Applied Biologics announced Last Patient, Last Visit (LPLV) in the 222-patient CAMPX multicenter...
SystImmune Advances SI-B037 Into Phase 1/1b Trial
Redmond, Washington, U.S., September 22, 2026 SystImmune, Inc. has announced that the U.S. Food and Drug Administration (FDA) has...
Q32 Bio to Present Bempikibart Data at EADV 2026
Waltham, Massachusetts, U.S., September 21, 2026 Q32 Bio Inc., a clinical-stage biotechnology company developing therapies for autoimmune and inflammatory...
Vera Therapeutics TRUTAKNA Shows Two-Year Kidney Benefit
Brisbane, California, USA, September 15, 2026 Vera Therapeutics has announced final efficacy results from the Phase 3 ORIGIN 3...
Twist Bioscience Joins Lilly TuneLab for Antibody Discovery
SOUTH SAN FRANCISCO, Calif. — September 16, 2026 Twist Bioscience Corporation announced an agreement with Lilly TuneLab, the collaborative...
Advertisement
